#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3892	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2214	504.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1843	1843	T	593	T,A,G	523,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3892	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2214	504.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1577	1577	C	567	C	482	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6250	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4000	467.9	0	.	n	.	0	A9G	SNP	9	9	A	528	528	G	531	G,A	450,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6250	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4000	467.9	0	.	n	.	0	T695C	SNP	695	695	T	1214	1214	C	471	C	400	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6250	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4000	467.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2490	2490	C	620	C,T,G	530,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6250	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4000	467.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3116	3116	T	586	T,C,A	489,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6250	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4000	467.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2564	2564	A	622	A	528	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	622	folP	855	855	99.77	folP.l6.c17.ctg.1	1953	95.3	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	1224	1226	AGC	149;149;149	A;G;C	124;127;126	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1158	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3874	89.4	0	.	p	.	0	T243I	NONSYN	727	729	ACA	1290	1292	ATA	78;78;77	A;T;A	67;68;71	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1158	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3874	89.4	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1311	1313	ATA	81;81;82	A;T;A	76;68;74	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1158	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3874	89.4	1	SNP	p	S91F	0	.	.	271	273	TCC	834	836	TCC	104;104;103	T;C,A;C	90;91,1;91	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1158	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3874	89.4	1	SNP	p	D95N	0	.	.	283	285	GAC	846	848	GAC	105;104;105	G;A;C	91;90;91	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1158	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3874	89.4	1	SNP	p	D95G	0	.	.	283	285	GAC	846	848	GAC	105;104;105	G;A;C	91;90;91	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	531	508	mtrR	633	633	99.69	mtrR.l6.c4.ctg.1	1853	82.1	0	.	p	.	0	P191fs	FSHIFT	571	571	C	1131	1131	C	130	C	113	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	531	508	mtrR	633	633	99.69	mtrR.l6.c4.ctg.1	1853	82.1	1	SNP	p	G45D	0	.	.	133	135	GGC	692	694	GGC	142;140;137	G;G;C	130;128;127	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	372	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1454	75.9	0	.	n	.	0	.206T	INS	206	206	T	786	786	T	143	T	124	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1238	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3386	109.5	0	.	p	.	0	V421A	NONSYN	1261	1263	GTC	1785	1787	GCC	127;127;127	G;C;C	118;115;116	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1238	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3386	109.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1827	1829	GCA	137;137;136	G;C;A	122;122;122	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1238	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3386	109.5	1	SNP	p	D86N	0	.	.	256	258	GAC	780	782	GAC	134;134;135	G;A,C;C	113;108,1;124	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1238	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3386	109.5	1	SNP	p	S87W	0	.	.	259	261	AGT	783	785	AGT	135;135;135	A,C;G;T,C	114,3;121;117,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1238	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3386	109.5	1	SNP	p	S87R	0	.	.	259	261	AGT	783	785	AGT	135;135;135	A,C;G;T,C	114,3;121;117,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1238	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3386	109.5	1	SNP	p	S87I	0	.	.	259	261	AGT	783	785	AGT	135;135;135	A,C;G;T,C	114,3;121;117,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1238	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3386	109.5	1	SNP	p	S88P	0	.	.	262	264	TCC	786	788	TCC	135;135;135	T,G;C;C	119,1;115;123	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_W_01411c	parE.WHO_W_01411c	1	1	27	1220	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3203	114.0	1	SNP	p	G410V	0	.	.	1228	1230	GGT	1822	1824	GGT	132;132;131	G,A;G;T	114,1;115;107	parE.WHO_W_01411c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	938	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2832	98.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1460	1462	GCA	124;124;124	G,A;C;A	107,1;107;111	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	938	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2832	98.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1463	1465	ATC	125;125;126	A;T;C	114;111;112	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	938	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2832	98.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1475	1477	GTG	129;130;129	G;T;G,T	112;110;112,1	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	938	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2832	98.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1475	1477	GTG	129;130;129	G;T;G,T	112;110;112,1	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	938	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2832	98.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1979	1981	ACC	104;105;105	A;C;C,G	90;87;92,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	938	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2832	98.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2033	2035	GCG	99;101;97	G;C;G	80;73;76	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	938	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2832	98.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2033	2035	GCG	99;101;97	G;C;G	80;73;76	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	938	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2832	98.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2156	2158	GGT	113;113;113	G;G;T	99;100;99	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	938	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2832	98.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2165	2167	GGC	114;114;112	G;G;C	101;96;97	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	938	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2832	98.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2183	2185	CCG	111;111;111	C,T;C;G	90,1;97;94	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1262	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3470	108.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1790	1792	CTG	103;103;105	C;T,C;GC,G	89;83,1;80,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	658	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2372	83.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	654	656	GGC	120;120;119	G;G;C	104;99;105	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	658	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2372	83.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	836	836	C	106	C	88	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	T18M	NONSYN	52	54	ACG	527	529	ATG	143;143;141	A;T,C;G	124;123,1;122	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	608	610	GTT	141;141;141	G;T;T,A	124;124;120,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	N121S	NONSYN	361	363	AAC	836	838	AGC	117;116;117	A;G,A;C	104;98,1;102	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	N122K	NONSYN	364	366	AAC	839	841	AAA	117;117;114	A;A;A	106;103;99	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	866	868	TAT	117;119;120	T;A;T,G	99;105;105,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	N134K	NONSYN	400	402	AAT	875	877	AAG	121;121;121	A;A;G	100;106;107	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	V135F	NONSYN	403	405	GTG	878	880	TTT	121;120;122	T,A;T;T	105,1;103;100	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	G140K	NONSYN	418	420	GGA	893	895	AAA	124;124;124	A;A;A	110;112;110	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	902	904	GAA	127;126;125	G,A;A;A	111,1;112;112	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	V151A	NONSYN	451	453	GTA	926	928	GCA	124;125;126	G;C;A	107;109;111	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	K207_M208insK	INS	619	619	A	1094	1094	A	142	A	130	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	A212S	NONSYN	634	636	GCA	1112	1114	TCA	145;145;147	T;C;A	125;128;127	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	710	porB1b	1038	1038	96.37	porB1b.l6.c4.ctg.1	1946	108.2	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1229	1229	T	151	T	134	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2732	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5350	153.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2254	2256	CAT	152;153;153	C;A;T	139;138;134	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	332	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1358	73.2	1	SNP	p	V57M	1	.	.	169	171	ATG	730	732	ATG	120;120;122	A;T;G	106;108;109	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
